Intersect ENT

Intersect ENT (NASDAQ: XENT) is a medical technology company dedicated to advancing the treatment of ear, nose and throat conditions through evidence-based innovation, providing physicians with solutions to overcome clinical challenges and improve the quality of life for patients. The company’s core technology is its bioabsorbable drug release platform and its current portfolio of sinus implants is designed to provide mechanical support and localized drug delivery for chronic sinus conditions. Intersect ENT was founded to find a better way to improve both the patient experience and surgical outcomes. Innovation backed by clinical evidence is a driving force of the company.

Intersect ENT is a publicly traded company and is based in Menlo Park, CA.